Atlas Trials

PD1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer

Clinical trial NCT07294664 · RECRUITING

Trial details

NCT number
NCT07294664
Sponsor
The First Affiliated Hospital of Zhengzhou University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Gastric CancerSHR1701
Start date
2025-06-15
Primary completion
2027-07-15
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.